Viewing StudyNCT00410163



Ignite Creation Date: 2024-05-05 @ 5:15 PM
Last Modification Date: 2024-10-26 @ 9:29 AM
Study NCT ID: NCT00410163
Status: COMPLETED
Last Update Posted: 2014-02-10
First Post: 2006-12-11

Brief Title: Ofatumumab With Fludarabine and Cyclophosphamide in B-CLL Patients
Sponsor: GlaxoSmithKline
Organization: GlaxoSmithKline

Conditions & Keywords Data

Conditions:
Name
Leukaemia Lymphocytic Chronic
Keywords:
Name View
B-cell View
cyclophosphamide View
fludarabine View
Chronic Lymphocytic Leukemia View
Ofatumumab View